Clinical Trial: Observational Non-Interventional Study Of Febrile Neutropenia Patients To Evaluate Antibacterial Therapeutical Options

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: Multi-Center, Non-Interventional, Observational Study To Evaluate The Antibacterial Therapeutical Options In Febrile Neutropenia Patients

Brief Summary: The purpose of this study was to define and classify antibacterial agents used in Turkey for patients with febrile neutropenia.

Detailed Summary:
Sponsor: Pfizer

Current Primary Outcome:

  • Percentage of Participants Receiving Antibacterial Agents Preferred by the Turkish Centers Monitoring Febrile Neutropenia (FEN) in Their Therapeutical Approach: Empirical [ Time Frame: Baseline ]
  • Percentage of Participants Receiving Antibacterial Agents Preferred by the Turkish Centers Monitoring FEN in Their Therapeutical Approach: Targeted [ Time Frame: Baseline ]


Original Primary Outcome: Definition and classification of the antibacterial agents preferred by the Turkish centers monitoring FEN in their therapeutical approach; empirical, targeted.. [ Time Frame: 1 year ]

Current Secondary Outcome:

  • Mean Body Temperature [ Time Frame: Baseline, Day 4, Day 7 on Average (till the End of Treatment) ]
  • Mean Neutrophil Count [ Time Frame: Baseline, Day 4, Day 7 on Average (till the End of Treatment) ]
  • Percentage of Participants in Whom New Infection Was Determined on Day 4 [ Time Frame: Day 4 ]
  • Percentage of Participants in Whom New Infection Was Determined at End of Treatment [ Time Frame: Day 7 on Average (till the End of Treatment) ]
  • Percentage Survivors [ Time Frame: Day 7 on Average (till the End of Treatment) ]
  • Percentage of Participants Who Had a Treatment Modification [ Time Frame: Day 4, Day 7 on Average (till the End of Treatment) ]


Original Secondary Outcome: Determination of the efficacy and safety of the used antibacterial agents [ Time Frame: 1 year ]

Information By: Pfizer

Dates:
Date Received: July 23, 2009
Date Started: June 2009
Date Completion:
Last Updated: March 7, 2017
Last Verified: March 2017